(19)
(11) EP 2 907 822 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.04.2018 Bulletin 2018/16

(45) Mention of the grant of the patent:
14.02.2018 Bulletin 2018/07

(21) Application number: 13845025.9

(22) Date of filing: 08.10.2013
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
A61K 38/17(2006.01)
A61P 43/00(2006.01)
 C12N 15/12(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/CN2013/084838
(87) International publication number:
WO 2014/056422 (17.04.2014 Gazette 2014/16)

(54)

HNRNP A2* PROTEIN, NUCLEIC ACID FOR CODING PROTEIN AND USE THEREOF

HNRNP A2*PROTEIN, NUKLEINSÄURE ZUR PROTEINCODIERUNG UND VERWENDUNG DAVON

PROTÉINE HNRNP A2*, ACIDE NUCLÉIQUE CODANT POUR LADITE PROTÉINE ET SON UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.10.2012 CN 201210383136

(43) Date of publication of application:
19.08.2015 Bulletin 2015/34

(73) Proprietor: Institute Of Zoology, Chinese Academy Of Sciences
Beijing 100101 (CN)

(72) Inventors:
  • TAN, Zheng
    Beijing 100101 (CN)
  • ZHAO, Yong
    Beijing 100101 (CN)
  • WANG, Feng
    Beijing 100101 (CN)
  • HAO, Yuhua
    Beijing 100101 (CN)

(74) Representative: Hryszkiewicz, Danuta et al
Matthias Scholl, Inc. Friedrichstrasse 123
10117 Berlin
10117 Berlin (DE)


(56) References cited: : 
CN-A- 1 325 862
   
  • KIM, M.J. ET AL.: 'hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere' NUCLEIC ACIDS RESEARCH vol. 33, no. 2, 19 January 2005, pages 486 - 496, XP055246695
  • DATABASE GENBANK [Online] 07 October 2012 'HOMO SAPIENS HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1 (HNRNPA2B1), TRANSCRIPT VARIANT A2, MRNA', XP055246696 Retrieved from NCBI Database accession no. NM_002137
  • KIM, M.J. ET AL.: 'Telomere- and telomerase-interacting protein that unfolds telomere G-quadruplex and promotes telomere extension in mammalian cells' PNAS vol. 109, no. 50, 11 December 2012, pages 20413 - 20418, XP055246711
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).